Pulmokine's Seed VC Round

Pulmokine raised a round of funding on March 03, 2015. Investors include Broadview Ventures.

Pulmokine is a privately held biopharmaceutical company. The mission of Pulmokine is to develop new treatments for pulmonary hypertension and related disorders. Pulmokine has an exclusive license from…

Articles about Pulmokine's Seed VC Round: